MICROENCAPSULATED IMAGING BIOMARKER AGENTS USED

Brand Owner Address Description
PREVUE Critical Care Innovations, Inc. 13901 Willard Rd. Chantilly VA 20153 Microencapsulated imaging biomarker agents used for pre and post operatively monitoring dignostic and therapeutic tissue sites;PRE VUE; PREVIEW;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Methods and compositions for identifying high-grade cervical disease in a patient sample are provided. The methods of the invention comprise detecting overexpression of at least one biomarker in a body sample, wherein the biomarker is selectively overexpressed in high-grade cervical disease. In particular claims, the body sample is a cervical smear or monolayer of cervical cells. The biomarkers of the invention include genes and proteins that are involved in cell cycle regulation, signal transduction, and DNA replication and transcription. In particular claims, the biomarker is an S-phase gene. In some aspects of the invention, overexpression of a biomarker of interest is detected at the protein level using biomarker-specific antibodies or at the nucleic acid level using nucleic acid hybridization techniques. Kits for practicing the methods of the invention are further provided.